JP2015519322A5 - - Google Patents

Download PDF

Info

Publication number
JP2015519322A5
JP2015519322A5 JP2015509395A JP2015509395A JP2015519322A5 JP 2015519322 A5 JP2015519322 A5 JP 2015519322A5 JP 2015509395 A JP2015509395 A JP 2015509395A JP 2015509395 A JP2015509395 A JP 2015509395A JP 2015519322 A5 JP2015519322 A5 JP 2015519322A5
Authority
JP
Japan
Prior art keywords
alkyl
group
groups
cycloalkyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015509395A
Other languages
English (en)
Japanese (ja)
Other versions
JP6236702B2 (ja
JP2015519322A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/058840 external-priority patent/WO2013164292A1/en
Publication of JP2015519322A publication Critical patent/JP2015519322A/ja
Publication of JP2015519322A5 publication Critical patent/JP2015519322A5/ja
Application granted granted Critical
Publication of JP6236702B2 publication Critical patent/JP6236702B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015509395A 2012-04-30 2013-04-29 インダニルオキシジヒドロベンゾフラニル酢酸 Active JP6236702B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12166095 2012-04-30
EP12166095.5 2012-04-30
PCT/EP2013/058840 WO2013164292A1 (en) 2012-04-30 2013-04-29 Indanyloxydihydrobenzofuranylacetic acids

Publications (3)

Publication Number Publication Date
JP2015519322A JP2015519322A (ja) 2015-07-09
JP2015519322A5 true JP2015519322A5 (https=) 2016-06-23
JP6236702B2 JP6236702B2 (ja) 2017-11-29

Family

ID=48325664

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015509395A Active JP6236702B2 (ja) 2012-04-30 2013-04-29 インダニルオキシジヒドロベンゾフラニル酢酸

Country Status (7)

Country Link
US (1) US8809376B2 (https=)
EP (1) EP2844653B1 (https=)
JP (1) JP6236702B2 (https=)
AR (1) AR090879A1 (https=)
TW (1) TW201406739A (https=)
UY (1) UY34773A (https=)
WO (1) WO2013164292A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6314335B2 (ja) * 2013-02-06 2018-04-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新しいインダニルオキシジヒドロベンゾフラニル酢酸
EP3068788A1 (en) 2013-11-14 2016-09-21 Cadila Healthcare Limited Novel heterocyclic compounds
BR102018007822A2 (pt) 2017-04-20 2018-11-06 Gilead Sciences, Inc. composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
CR20200347A (es) 2018-02-13 2020-09-23 Gilead Sciences Inc Inhibidores pd-1/pd-l1
TWI712412B (zh) 2018-04-19 2020-12-11 美商基利科學股份有限公司 Pd‐1/pd‐l1抑制劑
SG11202012425QA (en) 2018-07-13 2021-01-28 Gilead Sciences Inc Pd-1/pd-l1 inhibitors
WO2020086556A1 (en) 2018-10-24 2020-04-30 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
CN110372651A (zh) * 2019-07-22 2019-10-25 上海师范大学 一种含苯并呋喃骨架的茚衍生物的合成方法
KR20220150270A (ko) 2019-10-07 2022-11-10 칼리오페, 인크. Gpr119 효능제
TW202140440A (zh) 2020-02-28 2021-11-01 美商克力歐普股份有限公司 Gpr40激動劑
WO2021236617A1 (en) 2020-05-19 2021-11-25 Kallyope, Inc. Ampk activators
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2505322A1 (en) 2002-11-08 2004-05-21 Takeda Pharmaceutical Company Limited Receptor function regulator
JP4594611B2 (ja) * 2002-11-08 2010-12-08 武田薬品工業株式会社 受容体機能調節剤
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
EP1630152A4 (en) 2003-05-30 2009-09-23 Takeda Pharmaceutical CONDENSED CYCLIC COMPOUND
JP4805552B2 (ja) * 2003-05-30 2011-11-02 武田薬品工業株式会社 縮合環化合物
EP1924546A1 (en) 2005-09-14 2008-05-28 Amgen, Inc Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
KR20080103584A (ko) 2006-03-30 2008-11-27 아사히 가세이 파마 가부시키가이샤 치환 이환식 환상 유도체 및 그 용도
RS53230B (sr) 2006-06-27 2014-08-29 Takeda Pharmaceutical Company Limited Kondenzovana ciklična jedinjenja kao modulatori gpr40 receptora
KR20110027657A (ko) 2008-06-25 2011-03-16 다이이찌 산쿄 가부시키가이샤 카르복실산 화합물
AU2009303475B2 (en) 2008-10-15 2012-09-13 Amgen Inc. Spirocyclic GPR40 modulators
WO2010143733A1 (en) 2009-06-09 2010-12-16 Takeda Pharmaceutical Company Limited Novel fused cyclic compound and use thereof
TW201643169A (zh) 2010-07-09 2016-12-16 艾伯維股份有限公司 作為s1p調節劑的螺-哌啶衍生物
DK2646425T3 (en) 2010-12-01 2015-08-24 Boehringer Ingelheim Int Indanyloxydihydrobenzofuranylacetic acids useful for the treatment of metabolic syndrome.

Similar Documents

Publication Publication Date Title
JP2015519322A5 (https=)
JP2009530398A5 (https=)
JP2010077141A5 (https=)
JP2017531038A5 (https=)
JP2013500314A5 (https=)
JP2009535307A5 (https=)
JP2013501008A (ja) 抗ウイルス性化合物ならびにそれを含む医薬組成物
JP2010524932A5 (https=)
JP2013519632A5 (https=)
JP2011527334A5 (https=)
JP2010514832A5 (https=)
JP2009533410A5 (https=)
JP2015523339A5 (https=)
JP2020507589A5 (https=)
CN103102348B (zh) 噁二唑类化合物及其制备方法、药物组合物及其用途
RU2012150108A (ru) Аналоги глюкагоноподобного пептида-1 и их применение
JP2010522710A5 (https=)
JP2019520344A5 (https=)
JP2009528997A5 (https=)
CN1159305C (zh) 新的2-(n-氰基亚氨基)噻唑烷-4-酮衍生物
JP2005526773A5 (https=)
JP2014517848A5 (https=)
JP2010514734A5 (https=)
HRP20150064T1 (hr) Kombinacija inzulina i derivata triazina te uporaba iste u lijeäśenju dijabetesa
JP2008530242A5 (https=)